ReGen Biologics, Inc. Provides Update On 510(k) Regulatory Submission

August 7, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--Aug. 7, 2006--In relation to correspondence received from the FDA, ReGen Biologics, Inc. (OTC: RGBI - News) provided an update today regarding the 510(k) submission for its collagen scaffold device.

Twitter
LinkedIn
Facebook
Email
Print

Regulatory